NCT07281755 Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
| NCT ID | NCT07281755 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northumbria University |
| Condition | Parkinson Disease(PD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-08 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-08-08 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this observational trial is to explore the validity and reliability of DANU smart socks when used for mobility assessments in people with Parkinson's. Using a series of laboratory gold standard equipment, this project aims to compare the metrics observed by DANU to the reference standards. No intervention is included. Specifically, this study will explore metrics relating to walking (gait) and balance of a Parkinson's cohort through a series of motor tasks. Moreover, this study seeks to investigate the clinical validity of DANU outcome metrics exploring relationships with clinical scales, fall history and prospective falls.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria. * Hoehn \& Yahr stages I-III * Able to attend Northumbria University, Newcastle Upon Tyne for study visits * Able to walk and stand unassisted for a minimum of 2-minutes Exclusion Criteria: * History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.) * Montreal Cognitive Assessment (MoCA) score \< 21 * Injury to the lower extremities within the past 6-weeks.
Contact & Investigator
Rodrigo Vitorio, PhD
PRINCIPAL INVESTIGATOR
Northumbria University
Frequently Asked Questions
Who can join the NCT07281755 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Parkinson Disease(PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07281755 currently recruiting?
Yes, NCT07281755 is actively recruiting participants. Contact the research team at gabriella.gatti@northumbria.ac.uk for enrollment information.
Where is the NCT07281755 trial being conducted?
This trial is being conducted at Newcastle upon Tyne, United Kingdom.
Who is sponsoring the NCT07281755 clinical trial?
NCT07281755 is sponsored by Northumbria University. The principal investigator is Rodrigo Vitorio, PhD at Northumbria University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.